New hope for kids with aggressive brain cancer: experimental stem cell therapy trial opens
NCT ID NCT07031765
Summary
This early-stage trial is testing whether a combination of specially prepared stem cells and an immunotherapy drug (nivolumab) can help children and young adults with aggressive brain tumors that have returned after standard treatment. The study involves 12 participants aged 4-26 who will undergo surgery and receive the experimental treatment. Researchers want to see if this approach is safe and feasible while looking for signs it might help control these difficult-to-treat cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health Shands Children's Hospital/Shands Hospital
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.